2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide(CAS: 290297-26-6)

This compound falls under regulatory guidelines such as REACH in the EU and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). It is recommended to consult the latest REACH documentation for specific requirements, including hazard classification, SDS preparation, and safety data. Additionally, the FDA and EPA may have specific regulations for its use, handling, and disposal in the United States.

There are several alternatives that can be considered in the synthesis, such as using 2-[3,5-dichlorophenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide or similar compounds with similar functional groups. Further exploration of synthetic routes can include the use of analogous compounds with slight modifications in the substituents to achieve similar properties.

The market trend for this compound is driven by its use in pharmaceutical and research applications, particularly in the development of potent and selective inhibitors. Research is focusing on its potential in treating various diseases, including cancer. The compound is also being explored for its pharmacological properties, such as its ability to modulate specific protein targets.

Waste containing this compound should be collected in appropriate containers and disposed of according to local regulations. Incineration is a common method for disposal, ensuring complete destruction of the compound to minimize environmental impact. For professional disposal, contact hazardous waste management services to ensure compliance with all environmental protection precautions and regulatory requirements.